WIRB - A PHASE 2, FIXED-SEQUENCE, OPEN-LABEL, SWITCH-OVER STUDY OF THE
WIRB - A PHASE 2, FIXED-SEQUENCE, OPEN-LABEL, SWITCH-OVER STUDY OF THE
批准号:
8167309
负责人:
Uta Lichter-Konecki
金额:
$1.22万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-20 至 2010-06-30
关键词:
AmmoniaBloodBlood specimenChildhoodComputer Retrieval of Information on Scientific Projects DatabaseDietDoseEnrollmentFundingGrantInstitutionMeasurementMole the mammalPharmaceutical PreparationsPhasePhenylacetatesPhenylbutyratesProtocols documentationResearchResearch PersonnelResourcesSafetySourceTimeUnited States National Institutes of HealthVisitdesignopen label
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
这是一项对HPN-100的固定序列、开放标记、长期(12-
月)用于评估HPN-100在儿科受试者中的安全性的安全扩展部分
并前瞻性评估HPN-100控制血氨的能力
和NaPBA一起。
受试者将接受NaPBA每日三次(TID),在第一周和
第二周给予相同的PBA摩尔当量的HPN-100。如果有安全的话
关于从NaPBA一步过渡到HPN-100的关切,调查员S
自由裁量权,过渡可以分两步进行,这样在第二周受试者可以
在接种前接受相当于PBA剂量的50%的NaPBA和50%的HPN-100
第3周PBA相当于HPN-100剂量的100%。连续的血液样本将会是
在每种药物达到稳定状态后收集用于PK和血氨评估,
这是在100%NaPBA或HPN-100启动后大约4天实现的
治疗。
完成部分研究切换的受试者将有机会
通过进入研究的安全扩展部分继续研究
接受开放标签HPN-100最长12个月的治疗。
在注册后但在研究完成之前退出方案的受试者将拥有
所有的安全评估,包括安全实验室和抽取的单一血样
苯丁酸酯(PBA)、活性代谢物苯乙酸酯(PAA)和
终末代谢产物苯乙酰谷氨酰胺(PAGN)。一天中血液流动的时间
抽取的样本将被记录下来,以及自上次服药以来的时间
有人了。
受试者在整个研究过程中将遵循研究人员规定的稳定饮食,并
饮食依从性将在每次研究访问时记录,包括转换部分和
本研究的安全延伸部分。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
This is a fixed-sequence, open-label, Switch Over study of HPN-100 with a long-term (12-
month) Safety Extension part designed to assess the safety of HPN-100 in pediatric subjects
and to prospectively assess the ability of HPN-100 to control blood ammonia as compared
with NaPBA.
Subjects will receive NaPBA three times daily (TID) with meals during the first week and the
same PBA mole-equivalent dose of HPN-100 during the second week. If there are safety
concerns regarding a single-step transition from NaPBA to HPN-100, at the investigator¿¿"s
discretion, the transition may occur in 2 steps such that in the second week subjects may
receive 50% of the PBA equivalent dose as NaPBA and 50% as HPN-100 before receiving
100% of the PBA equivalent dose as HPN-100 in the third week. Serial blood samples will be
collected for PK and blood ammonia assessments after each drug has reached steady state,
which is achieved approximately 4 days after initiation of 100% NaPBA or HPN-100
treatment.
Subjects who complete the Switch Over part of the study will be offered the opportunity to
continue in the study by entering the Safety Extension part of the study to continue
receiving open-label HPN-100 for up to 12 months.
Subjects who exit the protocol after enrollment but prior to completion of the study will have
all the safety assessments, including safety labs and a single blood sample drawn for
measurement of phenylbutyrate (PBA), the active metabolite phenylacetate (PAA), and the
terminal metabolite phenylacetylglutamine (PAGN). The time of day at which the blood
sample is drawn will be recorded as well as the time since the last dose of medication was
taken.
Subjects will follow a stable diet throughout the study as prescribed by the investigator and
dietary compliance will be recorded at each study visit for both the Switch Over part and
Safety Extension part of the study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Planning a Multicenter Cooling Trial for Hyperammonemic Metabolic Crises
-
批准号:8445667
-
项目类别:
-
资助金额:$16.92万
-
财政年份:2013
-
负责人:Uta Lichter-Konecki
-
依托单位:
LONGITUDINAL STUDY OF UREA CYCLE DISORDERS
-
批准号:8167341
-
项目类别:
-
资助金额:$1.96万
-
财政年份:2010
-
负责人:Uta Lichter-Konecki
-
依托单位:
LONGITUDINAL STUDY OF UREA CYCLE DISORDERS
-
批准号:7951104
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2008
-
负责人:Uta Lichter-Konecki
-
依托单位:
LONGITUDINAL STUDY OF UREA CYCLE DISORDERS
-
批准号:7717192
-
项目类别:
-
资助金额:$1.57万
-
财政年份:2007
-
负责人:Uta Lichter-Konecki
-
依托单位:
LONGITUDINAL STUDY OF UREA CYCLE DISORDERS
-
批准号:7608379
-
项目类别:
-
资助金额:$0.73万
-
财政年份:2006
-
负责人:Uta Lichter-Konecki
-
依托单位:
海外基金